Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

1.5K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.5K
Hypertension I: Introduction01:28

Hypertension I: Introduction

902
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
902
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

963
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
963
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

1.1K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.1K
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

445
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
445
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

4.3K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.3K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Primary aldosteronism.

Nature reviews. Disease primers·2026
Same author

Predictors of treatment response to mineralocorticoid receptor antagonists in primary aldosteronism: insights from the SPAIN-ALDO registry.

Journal of hypertension·2026
Same author

Sex Differences in the Usefulness of Unattended Blood Pressure Measurement in Patients with Arterial Hypertension.

High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension·2026
Same author

Impact of the Cosecretion of Cortisol on Surgical Outcomes and in the Urinary Steroid Profile in Primary Aldosteronism.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2026
Same author

Utility of the post-cosyntropin urinary metabolomic profile for the subtype diagnosis of primary aldosteronism.

Journal of hypertension·2026
Same author

Reaching Blood Pressure Control: A 30-Year Odyssey.

Hypertension (Dallas, Tex. : 1979)·2026
Same journal

Bilateral macronodular and micronodular hyperplasia: Biochemical, radiological and genetic diagnosis.

Vitamins and hormones·2026
Same journal

ACTH independent Cushing's syndrome: Diagnosis and etiology.

Vitamins and hormones·2026
Same journal

Biochemical diagnosis of hypercortisolism: When and how?

Vitamins and hormones·2026
Same journal

New tools for the diagnosis of hypercortisolism.

Vitamins and hormones·2026
Same journal

Cardiometabolic comorbidities in overt Cushing's syndrome.

Vitamins and hormones·2026
Same journal

Molecular profile of Cushing's syndrome.

Vitamins and hormones·2026
Ver todos los artículos relacionados

Video Experimental Relacionado

Updated: Feb 6, 2026

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

5.6K

Hipertensión de renina baja

Paolo Mulatero1, Silvia Monticone1, Jessica Goi1

  • 1Department of Medical Sciences, Internal Medicine Division and Hypertension Unit, University of Torino. Torino, Italy.

Vitamins and hormones
|February 4, 2026
PubMed
Resumen
Este resumen es generado por máquina.

La hipertensión de renina baja (LRH) abarca diversas afecciones que causan presión arterial alta con renina baja. Identificar subtipos específicos es crucial para tratamientos efectivos y dirigidos y para mejorar los resultados cardiovasculares.

Palabras clave:
AldosteronaSíndrome de LiddleHipertensión de renina bajaReceptor de mineralocorticoidesRenina

Más Videos Relacionados

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

793
Hemodynamic Characterization of Rodent Models of Pulmonary Arterial Hypertension
09:40

Hemodynamic Characterization of Rodent Models of Pulmonary Arterial Hypertension

Published on: April 11, 2016

21.7K

Videos de Experimentos Relacionados

Last Updated: Feb 6, 2026

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

5.6K
Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

793
Hemodynamic Characterization of Rodent Models of Pulmonary Arterial Hypertension
09:40

Hemodynamic Characterization of Rodent Models of Pulmonary Arterial Hypertension

Published on: April 11, 2016

21.7K

Área de la Ciencia:

  • Nefrología
  • Endocrinología
  • Medicina Cardiovascular

Sus antecedentes:

  • La hipertensión de renina baja (LRH) afecta al 30% de los pacientes hipertensos, presentándose como un grupo heterogéneo de trastornos.
  • Las características clave incluyen niveles bajos de renina, aumento de la reabsorción de sodio y expansión del volumen circulante.
  • La LRH abarca la hipertensión esencial y diversas causas secundarias, incluidos los trastornos monogénicos y el aldosteronismo primario.

Objetivo del estudio:

  • Describir el diagnóstico diferencial y los mecanismos subyacentes de las afecciones comunes de LRH.
  • Centrarse en las estrategias diagnósticas y terapéuticas para los subtipos de LRH.
  • Destacar las implicaciones terapéuticas del reconocimiento de fenotipos específicos de LRH.

Principales métodos:

  • Evaluación clínica, incluida la historia familiar.
  • Mediciones bioquímicas: niveles de renina, aldosterona y potasio.
  • Perfil genético para formas monogénicas.

Principales resultados:

  • El aldosteronismo primario es la causa secundaria más común de LRH.
  • Las formas monogénicas como el síndrome de Liddle y el exceso aparente de mineralocorticoides tienen perfiles distintos.
  • Las causas adquiridas incluyen la ingesta alta de sodio, enfermedades renales, inhibidores de la RAAS y el exceso de regaliz/cortisol.
  • La activación del receptor de mineralocorticoides y el aumento de la reabsorción de sodio son mecanismos patogénicos comunes.

Conclusiones:

  • El diagnóstico preciso de los subtipos de LRH es esencial para un tratamiento adaptado.
  • El reconocimiento de afecciones específicas de LRH mejora los resultados a largo plazo y reduce los eventos cardiovasculares.
  • La comprensión del continuo entre las formas esenciales y secundarias de LRH guía los enfoques terapéuticos.